245 related articles for article (PubMed ID: 31818681)
21. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
[TBL] [Abstract][Full Text] [Related]
22. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity.
Miyatake S; Touho H; Miyake N; Ohba C; Doi H; Saitsu H; Taguri M; Morita S; Matsumoto N
J Hum Genet; 2012 Dec; 57(12):804-6. PubMed ID: 22931863
[TBL] [Abstract][Full Text] [Related]
23. A new horizon of moyamoya disease and associated health risks explored through RNF213.
Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
[TBL] [Abstract][Full Text] [Related]
24. Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213.
Li F; Huang YY; Zhang S; Wang W
Br J Neurosurg; 2023 Dec; 37(6):1882-1885. PubMed ID: 35642380
[TBL] [Abstract][Full Text] [Related]
25. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.
Kamada F; Aoki Y; Narisawa A; Abe Y; Komatsuzaki S; Kikuchi A; Kanno J; Niihori T; Ono M; Ishii N; Owada Y; Fujimura M; Mashimo Y; Suzuki Y; Hata A; Tsuchiya S; Tominaga T; Matsubara Y; Kure S
J Hum Genet; 2011 Jan; 56(1):34-40. PubMed ID: 21048783
[TBL] [Abstract][Full Text] [Related]
26. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
[TBL] [Abstract][Full Text] [Related]
27. Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.
Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Mukasa A; Nakatomi H; Shimizu T; Saito N
Stroke; 2013 Oct; 44(10):2894-7. PubMed ID: 23970789
[TBL] [Abstract][Full Text] [Related]
28. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
29. Rapid contralateral progression of focal cerebral arteriopathy distinguished from RNF213-related moyamoya disease and fibromuscular dysplasia.
Araki Y; Takagi Y; Mineharu Y; Kobayashi H; Miyamoto S; Wakabayashi T
Childs Nerv Syst; 2017 Aug; 33(8):1405-1409. PubMed ID: 28497183
[TBL] [Abstract][Full Text] [Related]
30. Role of Ring Finger Protein 213 in Moyamoya Disease.
Ma YG; Zhang Q; Yu LB; Zhao JZ
Chin Med J (Engl); 2016 Oct; 129(20):2497-2501. PubMed ID: 27748344
[TBL] [Abstract][Full Text] [Related]
31. The Clinical and Vascular Characteristics of RNF213 c.14576G>A Variant-Related Intracranial Major Artery Disease in China.
Cheng W; Xue S; Wu F; Song X; Huang Q; Song H; Wu J
Behav Neurol; 2019; 2019():7908392. PubMed ID: 30992731
[TBL] [Abstract][Full Text] [Related]
32. De Novo Development of Moyamoya Disease in an Adult Female with a Genetic Variant of the RNF-213 Gene: Case Report.
Tashiro R; Fujimura M; Niizuma K; Endo H; Sakata H; Sato-Maeda M; Tominaga T
J Stroke Cerebrovasc Dis; 2017 Jan; 26(1):e8-e11. PubMed ID: 27789153
[TBL] [Abstract][Full Text] [Related]
33. RNF213-related susceptibility of Japanese CADASIL patients to intracranial arterial stenosis.
Yeung WTE; Mizuta I; Watanabe-Hosomi A; Yokote A; Koizumi T; Mukai M; Kinoshita M; Ohara T; Mizuno T
J Hum Genet; 2018 May; 63(5):687-690. PubMed ID: 29500468
[TBL] [Abstract][Full Text] [Related]
34. Hemorrhagic Onset Intracranial Artery Dissection of Middle Cerebral Artery Followed by Progressive Arterial Stenosis with Genetic Variant RNF213 p.Arg4810Lys (rs112735431).
Shinya Y; Miyawaki S; Nakatomi H; Shin M; Teraoka A; Saito N
World Neurosurg; 2020 Sep; 141():192-195. PubMed ID: 32438004
[TBL] [Abstract][Full Text] [Related]
35. Role of RNF213 polymorphism in defining quasi-moyamoya disease and definitive moyamoya disease.
Ishisaka E; Watanabe A; Murai Y; Shirokane K; Matano F; Tsukiyama A; Baba E; Nakagawa S; Tamaki T; Mizunari T; Tanikawa R; Morita A
Neurosurg Focus; 2021 Sep; 51(3):E2. PubMed ID: 34469872
[TBL] [Abstract][Full Text] [Related]
36. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
[TBL] [Abstract][Full Text] [Related]
37. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
[TBL] [Abstract][Full Text] [Related]
38. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
39. Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease.
An S; Kim T; Oh CW; Bang JS; Lee SU; Heo J
Sci Rep; 2019 Jun; 9(1):8614. PubMed ID: 31197213
[TBL] [Abstract][Full Text] [Related]
40. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease.
Sonobe S; Fujimura M; Niizuma K; Nishijima Y; Ito A; Shimizu H; Kikuchi A; Arai-Ichinoi N; Kure S; Tominaga T
Brain Res; 2014 Mar; 1552():64-71. PubMed ID: 24440776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]